This week’s stories captured the protein sector at a moment where visibility briefly met execution, even as pressure on fundamentals remained.

We begin with cell cultivated meat stepping out of policy debates and into popular culture. A widely viewed YouTube influencer visit brought production and taste to a mass audience, reopening questions about whether familiarity and reach can shift perception more effectively than regulatory milestones alone.

From culture to policy, attention then moved to Europe. New limits on meat advertising in a major capital signaled a firmer regulatory hand in shaping diets, suggesting that protein transition is increasingly being steered, not just encouraged.

The focus then turned to scale. With commercial readiness no longer treated as theoretical, industry attention sharpened around manufacturing realities, infrastructure, and what delivery at scale will demand in the near term.

Elsewhere, progress continued in quieter forms. A technical spin out and fresh funding pointed to ongoing efforts to improve production efficiency and advance cultivated meat technologies under tighter capital conditions.

Beyond cultivated meat, plant based continued its shift from niche to normal. For one company celebrating an anniversary, five years on, the emphasis is less on identity and more on integration, performance, and everyday use.

Finally, collaboration extended into cellular aquaculture, with new partnerships targeting scalability, a reminder that diversification remains part of the sector’s long-term trajectory.

As ever, the mix tells a more nuanced story than any single headline.

Enjoy reading, and as always, let us know which developments you think will have the biggest impact next.

🧬 Upside Foods returns to wider view as MrBeast spotlights cultivated chicken

📢 Amsterdam moves to curb meat advertising in bid to shift dietary norms

📅 Countdown begins for FPP/CMS Chicago 2026 as scale becomes tangible

🧪 Upside Foods spins out Lucius Labs to commercialize its cell culture media expertise

💰 Innocent Meat secures fresh funding to advance cultivated meat production technology

🌱 Planteneers marks five years as the Stern-Wywiol unit pushes plant-based from niche toward the mainstream

🐟 Cell4Food partners with AlgoCell to accelerate scalable cellular aquaculture development

🤖 Cargill earns a major innovation award as its AI strategy delivers measurable gains across the global food system

📊 Plant-based demand has not disappeared but matured, according to new analysis from ProVeg

🔀 Vegan Food Group breaks apart as VFC and Meatless Farm move forward as independent businesses

We’re back early this year – and this time we’re heading to the USA. The Future of Protein Production Chicago, co-located with the Cultured Meat Symposium, will take place 24-25 February 2026 and is set to bring together 500 attendees, 100 speakers, and +40 exhibitors. Expect two days packed with insights across cultivated meat, fermentation, plant-based innovation, and scale-up solutions – plus unbeatable networking with industry leaders, investors, and innovators. Book your tickets today to secure the best rate.

Then in the autumn, we return to Europe for The Future of Protein Production Amsterdam, taking place 4-5 November 2026. This flagship event will welcome 1,000 attendees, 100 speakers, and +60 exhibitors, all gathering under one roof to explore the breakthroughs shaping the next wave of alternative protein commercialization. From technical deep dives to strategic discussions, this is where the global industry meets. Reserve your place now to lock in the lowest rate.

💰 Financing a First-of-a-Kind: How Growth-Stage Fermentation Companies Bridge the Capital Gap

If you’re navigating the leap from pilot success to commercial-scale fermentation, this is a conversation you won’t want to miss. Join us on Thursday, January 29, 2026 (2pm London / 3pm Berlin / 9am New York City) for a timely deep dive into how growth-stage fermentation companies are financing first-of-a-kind industrial assets.

As fermentation businesses mature, many hit the same wall: equity alone is no longer enough, yet traditional lenders and infrastructure investors often hesitate to step in. The result is a capital gap that can stall even the most technically promising projects.

This free-to-attend webinar, held in partnership with Unibio, will explore what ‘bridging the gap’ really means in practice – and how companies are combining multiple forms of capital to move from pilot to production while managing risk on all sides. Whether you’re preparing for your first commercial facility, assessing finance-readiness, or evaluating biomanufacturing investments, this session will offer grounded insight into what’s working now – and what investors actually expect to see.

Join us to learn:

⚙️ Beyond venture capital: Why equity alone rarely funds industrial fermentation – and what comes next

🏗️ Blended finance in action: How debt, offtakes, strategic partners, and public–private capital can work together

📈 Investor expectations: The technical and operational milestones financiers look for before committing capital

🔍 Finance readiness: What it really means to be “bankable” at the point of scale-up

🤝 Risk-sharing models: How companies and capital partners are structuring first-of-a-kind projects today

Designed for founders, CFOs, scale-up leaders, investors, infrastructure specialists, and public-sector stakeholders, this session will take a clear-eyed look at the financial innovation needed to turn fermentation technology into productive industrial capacity.

🎙️💡 Listen to our latest episode now! What makes mycoproteins taste good? 🤔 Planetary’s Dr Muyiwa Akintoye explores how processing choices influence the bite, structure, and sensory performance of mycoprotein foods.🎙️🥩➡️🌱

Our weekly newsletter reaches more than 16,500 industry professionals, with engagement rates that consistently exceed industry standards.

Want to showcase your expertise to this growing community? Consider writing a guest article, Innovation Insight, or thought-leadership piece for our website and magazine.

📩 Interested? Email us at [email protected] and let’s discuss how we can feature your insights! 🚀

If you like our content, we think you will love these too…